Home > Insider Trading > Filing (0001209191-20-049862)

Filing Details

Accession Number:: 0001209191-20-049862
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-09 18:02:22
Reporting Period:: 2020-09-08

Accepted Time:: 2020-09-09 18:02:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891024	Patterson Companies Inc.	PDCO	Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)	410886515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1652545	B Les Korsh	1031 Mendota Heights Road St. Paul MN 55120	Vp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-09-08	3,111	$25.08	106,063	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,554	Indirect	By ESOP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Employee Stock Options	$23.57		2030-07-14	24,780	24,780	Direct
Common Stock	Employee Stock Options	$22.25		2029-07-01	33,784	33,784	Direct
Common Stock	Employee Stock Options	$22.48	2021-07-01	2028-07-01	14,179	14,179	Direct
Common Stock	Employee Stock Options	$47.51	2020-07-01	2027-07-01	11,845	11,845	Direct
Common Stock	Employee Stock Options	$48.47	2019-07-01	2026-07-01	10,379	10,379	Direct
Common Stock	Employee Stock Options	$56.66		2025-07-01	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-07-14	24,780	24,780	Direct
2029-07-01	33,784	33,784	Direct
2028-07-01	14,179	14,179	Direct
2027-07-01	11,845	11,845	Direct
2026-07-01	10,379	10,379	Direct
2025-07-01	25,000	25,000	Direct

Footnotes

The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on July 9, 2020.
Includes 13,911 restricted stock units ("RSUs") awarded on 7/1/2016, 7/1/2017, 7/1/2018, 7/1/2019 and 7/14/2020 to Reporting Person pursuant to the Patterson Companies, Inc. Amended and Restated 2015 Omnibus Incentive Plan ("Plan"). The RSUs vest contingent upon continued employment as follows: 6,799 units in aggregate vest on 7/1/2021, 1,393 units in aggregate vest on 7/1/2022, 946 units vest on 7/1/2023 and 4,773 units vest on 7/14/2023.
Includes 33,753 RSUs awarded to Reporting Person pursuant to a Restrictive Covenants, Severance and Change in Control Agreement between Patterson Companies, Inc. and the Reporting Person. Each RSU represents a right to receive one share of common stock upon vesting. The RSUs are issued under the Plan and will vest, contingent upon continued employment on 6/11/2021.
Includes 3,765 shares acquired pursuant to Reporting Person's participation in the Patterson Companies, Inc. Capital Accumulation Plan in the year 2018 and remain subject to the terms of such plan.
Includes 8,271 RSU equivalents attributable to the June 11, 2019 determination by the Compensation Committee that the performance criteria for the period of April 29, 2018 through April 27, 2019 applicable to non-derivative performance units issued on August 7, 2018 had been satisfied. Subject to continued employment of the Reporting Person through April 24, 2021, the RSU equivalents will automatically convert into shares of common stock.
Includes 14,410 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the RSU equivalents will automatically convert into shares of common stock.
Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through April 25, 2020.
Stock options granted pursuant to the Plan on 7/14/2020.
Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
Stock options granted pursuant to the Plan on 7/1/2019.
Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
Stock options granted pursuant to the Plan on 7/1/2018.
Stock options granted pursuant to the Plan on 7/1/2017.
Stock options granted pursuant to the Plan on 7/1/2016.
Stock options granted pursuant to the Patterson Companies, Inc. Amended and Restated Equity Incentive Plan on 7/1/2015.
Options are exercisable as follows: 25% on 7/1/2018, 25% on 7/1/2019 and 50% on 7/1/2020.